English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 27, 2025

Baylor College of Medicine partners with Hess on new STEM guide featuring stock car racers
+ Pharmaceuticals
Patient Daily | Nov 26, 2025

UTHealth Houston receives NIH grant to study long-term results of spina bifida treatment
+ Pharmaceuticals
Patient Daily | Nov 26, 2025

EPA delays methane emission rules despite concerns raised by lung association
+ Pharmaceuticals
Patient Daily | Nov 25, 2025

JK Strategies Founder Kalavritinos on 340B abuse: 'Money was not going to the people who needed it'
+ Pharmaceuticals
Patient Daily | Nov 25, 2025

Government extends Soft Drinks Levy to include sugary milk-based beverages
+ Pharmaceuticals
Patient Daily | Nov 25, 2025

Tobacco Free Action Communities marks 25 years fighting tobacco use in New York
+ Pharmaceuticals
Patient Daily | Nov 25, 2025

Bliksem Health founder Rojas on 340B reform: '340B has been weaponised by the largest entities and must be cut off'
+ Pharmaceuticals
Patient Daily | Nov 21, 2025

Texas voters approve $3 billion funding plan for new Dementia Prevention institute

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes